| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Radiology, Nuclear Medicine and Imaging | 238 / 361 | 34th | Q3 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Nuklearmedizin - NuclearMedicine
Nuklearmedizin - NuclearMedicine is Scopus-indexed (Q3, CiteScore 1.8), WoS SCIE. Published by Georg Thieme Verlag.
Checked against the index lists dated .
ISSN 0029-5566Verify ISSN ↗2567-6407Verify ISSN ↗
Publisher: Georg Thieme Verlag
Cost to publish: No APC data — check the publisher
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Nuklearmedizin - NuclearMedicine indexed in Scopus?
Yes — actively indexed in Scopus, coverage 1959–present, best quartile Q3, CiteScore 1.8.
What quartile is Nuklearmedizin - NuclearMedicine in Scopus?
Nuklearmedizin - NuclearMedicine is Q3 in Radiology, Nuclear Medicine and Imaging (rank 238 of 361), by CiteScore 2025.
What is the impact factor of Nuklearmedizin - NuclearMedicine?
Nuklearmedizin - NuclearMedicine is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.8, which places it in quartile Q3 at the 34th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.277, quartile Q3, with an H-index of 44.
Who publishes Nuklearmedizin - NuclearMedicine and what is its ISSN?
Nuklearmedizin - NuclearMedicine is published by Georg Thieme Verlag. Its print ISSN is 0029-5566 and its online ISSN is 2567-6407.
Is Nuklearmedizin - NuclearMedicine in Web of Science?
Yes — indexed in the Science Citation Index Expanded.
Is Nuklearmedizin - NuclearMedicine open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Nuklearmedizin - NuclearMedicine? — open metrics via OpenAlex
Nuklearmedizin - NuclearMedicine has an h-index of 46 and a 2-year mean of 0.17 citations per paper (OpenAlex). Its Scopus CiteScore is 1.8, quartile Q3. On 2-year citations it ranks #304 of 346 Scopus journals in Radiology, Nuclear Medicine and Imaging.
Nuklearmedizin - NuclearMedicine published 264 papers in 2025; its busiest recent year was 2020 with 395. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Nuklearmedizin - NuclearMedicine? — latest 95 articles, 2026
In its latest 95 research articles (2026), authors are most often from Germany (81.7%), Switzerland (4.3%) and Austria (2.9%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Nuklearmedizin - NuclearMedicine? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
- Author concentration81.7% of recent authorship from Germany
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.